| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |